Blueblood Ventures Limited Files SEBI Compliance Certificate for Q4FY26
Blueblood Ventures Limited submitted its quarterly SEBI compliance certificate for Q4FY26 ended March 31, 2026, under Regulation 74(5) of SEBI (Depository Participant) Regulations. The certificate, signed by Managing Director Suresh Bohra and filed with BSE Limited on April 8, 2026, confirms no physical share certificates were received for dematerialization during the quarter. Skyline Financial Services Private Limited, the company's RTA, provided the confirmation certificate.
*this image is generated using AI for illustrative purposes only.
Blueblood Ventures Limited has fulfilled its quarterly regulatory obligations by submitting a compliance certificate under SEBI (Depository Participant) Regulations to BSE Limited. The submission, dated April 8, 2026, covers the quarter ended March 31, 2026, and demonstrates the company's adherence to mandatory reporting requirements.
Regulatory Compliance Details
The certificate was filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation requires companies to report on dematerialization activities during each quarter. Managing Director Suresh Bohra (DIN: 00093343) signed the submission on behalf of Blueblood Ventures Limited.
| Parameter: | Details |
|---|---|
| Reporting Quarter: | Q4FY26 ended March 31, 2026 |
| Filing Date: | April 8, 2026 |
| Regulation: | SEBI Regulation 74(5) |
| Signatory: | Suresh Bohra, Managing Director |
| Exchange: | BSE Limited |
Certificate Confirmation
Skyline Financial Services Private Limited, serving as the company's Registrar and Share Transfer Agent (RTA), issued the confirmation certificate dated April 1, 2026. The certificate confirms that no physical share certificates were received for dematerialization of equity shares during the quarter ended March 31, 2026.
Parveen Sharma, Authorised Signatory of Skyline Financial Services Private Limited, signed the certificate confirming the dematerialization status for Blueblood Ventures Limited (CIN: L70102DL2007PLC159680).
Company Information
Blueblood Ventures Limited maintains its registered office at M-55, 3rd Floor M-Block Market Greater Kailash-II New Delhi 110048. The company operates under the email address blueblood@blackfoxindia.com and maintains its corporate website at www.bluebloodventure.com .
The quarterly filing represents standard regulatory compliance, ensuring transparency in the company's share dematerialization processes and maintaining good standing with market regulators.
What factors might be driving the absence of physical share dematerialization requests for Blueblood Ventures in Q4FY26?
How will SEBI's evolving regulatory framework for depositories impact Blueblood Ventures' compliance costs in FY27?
What strategic initiatives might Blueblood Ventures pursue to increase investor engagement and trading activity?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
